Life science researchers to pitch ideas at Biomedical Innovation Cup
What if you could possibly help prevent another stroke in a patient? Or what if you could increase the chances of preventing blindness in someone with diabetes?
Innovations like these could take another step on the path to reality at the 2017 Biomedical Innovation Cup on May 17 at the Michigan Growth Capital Symposium, when teams from the U-M Translational Research and Commercialization (MTRAC) for Life Sciences Innovation Hub — funded by the Michigan Economic Corporaton — will pitch their biomedical innovations to investment “sharks” for a chance to be crowned this year’s winner.
The Innovation Cup caps off the annual symposium, a two-day venture capital investment event in Ypsilanti on May 16-17.
Hosted by Paul Riser, managing director of Tech Town Detroit, Innovation Cup is the culmination of entrepreneurial training that prepares MTRAC teams to seek investors for their potential innovations.
“Increasingly, Michigan is a nexus of companies and research organizations pushing boundaries,” Riser said. “The Biomedical Innovation Cup is a unique opportunity for our innovation ecosystem to showcase its strength as a biomedical hub to the world.”
At the Innovation Cup, five teams will pitch their projects, which range from a new method for the detection of heart irregularities to a drug for scleroderma to a diagnostic for blindness. They’ll be judged by a panel of biomedical investment experts from Three Leaf Ventures, BioMotiv, Bloom + Burton and Rivervest Venture Partners. Click here for the list of projects and judges.
“With this pitch competition, MTRAC teams benefit from gaining a ‘real-life’ perspective on their projects and commercialization plans,” said Brad Martin, Ph.D., FFMI senior director of commercialization programs. “It’s one step closer to taking their drugs and technologies to market, where they can ultimately help patients.”
For more information and to RSVP, click here.